Literature DB >> 16133853

Intra-cardiac echocardiography guided cardioversion to help interventional procedures (ICE-CHIP) study: study design and methods.

Hygriv B Rao1, Sanjeev Saksena, Ravi Mitruka.   

Abstract

The ICE CHIP study is a sequential Phase I and Phase II pilot study comparing the cardiac imaging capabilities of intracardiac echocardiography (ICE) with with transesophageal echocardiography (TEE) followed by a randomized comparison of ICE guided cardioversion with a conventional cardioversion strategy in patients with atrial fibrillation. It is a prospective open label randomized multi-center investigation performed in two phases designed to initially compare two distinct imaging modalities (Phase 1) and subsequently two different strategies (ICE guided Cardioversion and Conventional) in the management of AF in patients undergoing invasive cardiac procedures in whom electrical cardioversion is indicated (Phase 2). This study will examines two hypotheses in AF patients undergoing invasive cardiac procedures: (1) ICE has comparable efficacy to TEE in visualization of left atrial pathology including thrombi or interatrial septal defects. This will be evaluated during the Phase I component of the study. (2) ICE can identify low risk patients in whom immediate cardioversion during the procedure is safe and comparably effective to electrical cardioversion performed based on a conventional strategy of a minimum of 3 weeks of preceding anticoagulation therapy. Phase 1 will enroll 100 patients at 12 centers, who will undergo a clinically indicated TEE procedure and cardiac catheterization procedure. Each patient will be imaged by TEE & ICE and a core echo laboratory will perform a blinded comparison of the two imaging modalities. In Phase 2, a total of 300 patients (3:2 randomization) will be enrolled in the study at up to 15 investigational sites in USA and Europe. The composite incidence rate of major cardiac and bleeding complications (stroke, TIA, peripheral embolism, major hemorrhagic event) will be compared between the two treatment groups over the duration of the study.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16133853     DOI: 10.1007/s10840-005-1069-4

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  10 in total

1.  Nonfluoroscopic transseptal catheterization: safety and efficacy of intracardiac echocardiographic guidance.

Authors:  L M Epstein; T Smith; H TenHoff
Journal:  J Cardiovasc Electrophysiol       Date:  1998-06

2.  Intracardiac phased-array imaging: methods and initial clinical experience with high resolution, under blood visualization: initial experience with intracardiac phased-array ultrasound.

Authors:  Douglas L Packer; Carolyn L Stevens; Michael G Curley; Charles J Bruce; Fletcher A Miller; Bijoy K Khandheria; Jae K Oh; Lawrence J Sinak; James B Seward
Journal:  J Am Coll Cardiol       Date:  2002-02-06       Impact factor: 24.094

3.  Usefulness of transesophageal echocardiography for the detection of left atrial thrombi in patients with rheumatic heart disease.

Authors:  S L Lin; T L Hsu; J Y Liou; C H Chen; M S Chang; H T Chiang; C Y Chen
Journal:  Echocardiography       Date:  1992-03       Impact factor: 1.724

4.  Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation.

Authors:  A L Klein; R A Grimm; R D Murray; C Apperson-Hansen; R W Asinger; I W Black; R Davidoff; R Erbel; J L Halperin; D A Orsinelli; T R Porter; M F Stoddard
Journal:  N Engl J Med       Date:  2001-05-10       Impact factor: 91.245

5.  Transcatheter closure of atrial septal defects and patent foramen ovale under intracardiac echocardiographic guidance: feasibility and comparison with transesophageal echocardiography.

Authors:  Z Hijazi; Z Wang; Q Cao; P Koenig; D Waight; R Lang
Journal:  Catheter Cardiovasc Interv       Date:  2001-02       Impact factor: 2.692

6.  Left atrial thrombus associated with ablation for atrial fibrillation: identification with intracardiac echocardiography.

Authors:  Jian-Fang Ren; Francis E Marchlinski; David J Callans
Journal:  J Am Coll Cardiol       Date:  2004-05-19       Impact factor: 24.094

7.  Prevalence and clinical implications of atrial spontaneous contrast in patients undergoing transesophageal echocardiography.

Authors:  R Castello; A C Pearson; A J Labovitz
Journal:  Am J Cardiol       Date:  1990-05-01       Impact factor: 2.778

8.  Phased-array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation: impact on outcome and complications.

Authors:  Nassir F Marrouche; David O Martin; Oussama Wazni; A Marc Gillinov; Allan Klein; Mandeep Bhargava; Eduardo Saad; Dianna Bash; Hirotsugu Yamada; Wael Jaber; Robert Schweikert; Patrick Tchou; Ahmad Abdul-Karim; Walid Saliba; Andrea Natale
Journal:  Circulation       Date:  2003-05-19       Impact factor: 29.690

9.  Superiority of transesophageal echocardiography in detecting cardiac source of embolism in patients with cerebral ischemia of uncertain etiology.

Authors:  A C Pearson; A J Labovitz; S Tatineni; C R Gomez
Journal:  J Am Coll Cardiol       Date:  1991-01       Impact factor: 24.094

10.  Role of right atrial endocardial structures as barriers to conduction during human type I atrial flutter. Activation and entrainment mapping guided by intracardiac echocardiography.

Authors:  J E Olgin; J M Kalman; A P Fitzpatrick; M D Lesh
Journal:  Circulation       Date:  1995-10-01       Impact factor: 29.690

  10 in total
  1 in total

Review 1.  Intracardiac Echocardiography for Structural Heart and Electrophysiological Interventions.

Authors:  Craig Basman; Yuvrajsinh J Parmar; Itzhak Kronzon
Journal:  Curr Cardiol Rep       Date:  2017-09-06       Impact factor: 2.931

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.